1918156-05-4: Clorabacavir Racemic

Status: In-stock

Clorabacavir Racemic (CAS No: 1918156-05-4) is an impurity formed during the synthesis of Abacavir which is a nucleoside reverse transcriptase inhibitor used in the treatment of human immunodeficiency virus infection. It acts by inhibiting HIV reverse transcriptase by competing with the endogenous substrate dGTP.

Additional information on CAS 1918156-05-4

Catalogue No. VL760012
CAS No. 1918156-05-4
Molecular Formula C11H12ClN5O : HCl
Molecular Weight 302.16 g/mol
Parent drug Abacavir
IUPAC Name ((1S, 4R)-4-(2-amino-6-chloro-9H-purin-9-yl)cyclopent-2-en-1-yl)methanol hydrochloride
Synonyms N/A
References Vukkum, Pallavi. “Stress Degradation Behavior of Abacavir Sulfate and Development of a Suitable Stability-Indicating UHPLC Method for the Determination of Abacavir, Its Related Substances, and Degradation Products.” Scientia Pharmaceutica, vol. 80, no. 4, 2012, pp. 903–21, https://doi.org/10.3797/scipharm.1206-11.
Status In-stock

Request a quote

We Respond Within a Few Hours - Whether You're a New or Existing Client

Payment Made Simple: All major Credit/Debit cards accepted

Streamlined 3-Step Process from Quotes to Orders:

Product name:

1918156-05-4: Clorabacavir Racemic

"*" indicates required fields

Products quotation
This field is for validation purposes and should be left unchanged.